Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes

Cardiovasc Res. 2003 Jun 1;58(3):535-48. doi: 10.1016/s0008-6363(03)00255-4.

Abstract

Objective: The aim of this study was to characterize the spatio-temporal dynamics of [Ca(2+)](i) in rat heart in the fetal and neonatal periods.

Methods: Using confocal scanning laser microscopy and the Ca(2+) indicator fluo-3, we investigated Ca(2+) transients and Ca(2+) sparks in single ventricular myocytes freshly isolated from rat fetuses and neonates. T-tubules were labeled with a membrane-selective dye (di-8-ANEPPS). Spatial association of dihydropyridine receptors (DHPR) and ryanodine receptors (RyR) was also examined by double-labeling immunofluorescence.

Results: Ca(2+) transients in the fetal myocytes were characterized by slower upstroke and decay of [Ca(2+)](i) compared to those in adult myocytes. The magnitude of fetal Ca(2+) transients was decreased after application of ryanodine (1 microM) or thapsigargin (1 microM). However, Ca(2+) sparks were rarely detected in the fetal myocytes. Frequent ignition of Ca(2+) sparks was established in the 6-9-day neonatal period, and was predominantly observed in the subsarcolemmal region. The developmental change in Ca(2+) sparks coincided with development of the t-tubule network. The immunofluorescence study revealed colocalization of DHPR and RyR in the postnatal period, which was, however, not observed in the fetal period. In the adult myocytes, Ca(2+) sparks disappeared after disruption of t-tubules by glycerol incubation (840 mM).

Conclusions: The sarcoplasmic reticulum (SR) of rat ventricular myocytes already functions early in the fetal period. However, ignition of Ca(2+) sparks depends on postnatal t-tubule formation and resultant colocalization of DHPR and RyR.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Analysis of Variance
  • Calcium / metabolism*
  • Calcium Channel Agonists / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Calcium Channels, L-Type / metabolism
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Fluorescent Antibody Technique, Indirect
  • Heart / embryology*
  • Heart / growth & development
  • Heart Conduction System / physiology*
  • Humans
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / ultrastructure
  • Ryanodine / pharmacology
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum / metabolism
  • Thapsigargin / pharmacology

Substances

  • Calcium Channel Agonists
  • Calcium Channels
  • Calcium Channels, L-Type
  • Enzyme Inhibitors
  • Ryanodine Receptor Calcium Release Channel
  • Ryanodine
  • Thapsigargin
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Calcium